Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Relief Therapeutics Holding AG
  6. Company
    RLF   CH0100191136

RELIEF THERAPEUTICS HOLDING AG

(RLF)
  Report
Real-time Estimate Quote. Real-time Estimate  - 12/08 05:19:55 pm
0.0620 CHF   -2.52%
11/30Relief Therapeutics Appoints Chief Medical Officer, Other Executives
MT
11/30Relief Therapeutics Announces Executive Changes
EQ
11/30Relief Therapeutics Announces Executive Changes
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Relief Therapeutics Holding AG
RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The Company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases.
Managers
Name Title Age Since
Jack M. Weinstein Chief Financial Officer & Treasurer 64 2020
Nermeen Varawalla, Dr. Chief Medical Officer - 2021
Taneli Jouhikainen, Dr. Chief Operating Officer 53 2021
Raghuram Selvaraju, Dr. Chairman 42 2016
Marco Marotta Chief Business Officer - 2021
Anthony M. Kim Senior VP & Head-US Commercial Operations - 2021
Jeremy Meinen Chief Accounting Officer - 2021
Members of the board
Name Title Age Since
Raghuram Selvaraju, Dr. Chairman 42 2016
Thomas Plitz, Dr. Director 52 2020
Paolo Galfetti Director - -
Patrice P. Jean Director - 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,434,096,809 2,797,993,918 63.1% 24,362,841 0.5% 63.1%
Shareholders
NameEquities%
Global Emerging Markets North America, Inc. 1,158,000,000 26.3%
Relief Therapeutics Holding AG 413,815,700 9.38%
BG Consulter GmbH 136,343,167 3.09%
Yves Sagot 75,401,533 1.71%
BlackRock Fund Advisors 23,008,309 0.52%
Credit Suisse Asset Management (Schweiz) AG 22,265,646 0.50%
Gaël Hédou 16,375,998 0.37%
UBS Asset Management Switzerland AG 15,304,000 0.35%
Zürcher Kantonalbank (Investment Management) 12,678,834 0.29%
Michel Dreano 4,333,334 0.098%
Holdings
NameEquities%Valuation
RELIEF THERAPEUTICS HOLDING AG (RLF) 413,815,700 9.38% 35,778,505 USD
Company contact information
RELIEF THERAPEUTICS Holding AG
Avenue de Sécheron 15
Bâtiment F2/F3
Geneva, Geneve (Geneva) 1202

Phone : +41.44.723.59.59
Fax : +41.44.726.90.12
Web : http://www.relieftherapeutics.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Relief Therapeutics Holding AG